A phase II clinical trial evaluating the safety and efficacy of durvalumab as first line therapy in advanced and metastatic non-small cell lung cancer patients with Eastern Cooperative Oncology Group performance status of 2
Article
Shaverdashvili, Khvaramze; Reyes, Vincent; Wang, Hong; Mehta, Dhaval; Marsh, Christopher; Waas, John K.; Vanderweele, Robert A.; Peracha, Sajid M.; Liang, Hongmei; Socinski, Mark A.; Gerber, David E.; Dowell, Jonathan E.; Villaruz, Liza C.